Pre-Open Stock Movers 12/28: (AQMS) (MARA) (BTU) Higher; (APRE) (NNDM) (LMND) Lower (more...)

December 28, 2020 9:14 AM EST
Get Alerts APRE Hot Sheet
Price: $4.55 -5.6%

Overall Analyst Rating:
    NEUTRAL (Up Up)

Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Pre-Open Stock Movers:

Aprea Therapeutics, Inc. (Nasdaq: APRE) 73.5% LOWER; announced results of the primary data cut from its Phase 3 clinical trial evaluating the safety and efficacy of eprenetapopt with azacitidine (AZA) versus AZA alone in TP53 mutant myelodysplastic syndromes (MDS). The trial did not meet the predefined primary endpoint of complete remission (CR) rate. Analysis of the primary endpoint at this data cut demonstrated a higher CR rate in the experimental arm receiving eprenetapopt with AZA versus the control arm receiving AZA alone, but did not reach statistical significance. In the intention-to-treat population of 154 patients, the CR rate in the eprenetapopt with AZA arm was 33.3% (95% CI: 23.1% - 44.9%) compared to 22.4% (95% CI: 13.6% - 33.4%) in the AZA alone arm (P = 0.13).

Aqua Metals, Inc. (NASDAQ: AQMS) 40% HIGHER; announced it has completed its V1.25L electrolyzer program on time and under budget, achieving lead production that is 100% greater compared to the V1.0 electrolyzer deployed at the AquaRefinery during commercial production in 2018 and 2019. The Company previously guided a 20% increase of throughput, yet the V.125L electrolyzer surpassed that guidance by 500%. The V1.25L program concluded with a multi-day 24/7 endurance run that ended on December 24th.

Marathon Patent Group, Inc. (NASDAQ: MARA) 28% HIGHER; entered into a contract with Bitmain to purchase 70,000 Antminer S-19 ASIC miners.

Peabody (NYSE: BTU) 27% HIGHER; has entered into a transaction support agreement with 100 percent of its revolving lenders and letter of credit issuers and approximately 65 percent of its 6.000% senior secured notes due 2022 that contemplates a comprehensive financing solution to extend certain of Peabody's debt maturities and grant financial covenant relief, while maintaining sufficient operating liquidity and financial flexibility.

Ideanomics (NASDAQ: IDEX) 17.2% HIGHER; announces that its Mobile Energy Global and its contracting entity Qingdao Chengyang Medici have signed an agreement with Meihao Chuxing, a joint venture between BYD and Didi, to purchase an initial 2,000 units of model BYD D1. The ride-hailing vehicles are intended for deployment in multiple cities within China, with deliveries expected to begin in H1 2021.

Ashford Hospitality Trust, Inc. (NYSE: AHT) 14% HIGHER; announced that the Company has secured a strategic financing commitment from funds managed by Oaktree Capital Management, L.P. to provide a $200 million senior secured term loan. In addition, the financing commitment can be upsized by $150 million to an aggregate amount of $350 million.

Nano Dimension Ltd. (NASDAQ: NNDM) 9.3% LOWER; announced it has entered into definitive agreements with investors for the sale of 33,333,334 of the Company’s American Depositary Shares (“ADSs”) at a price of $7.50 per ADS pursuant to a registered direct offering. The gross proceeds of the offering will be approximately $250 million, before deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds for working capital and for other general corporate purposes, and pursuing strategic opportunities, including possible business combination transactions. The closing of the registered direct offering is expected to take place on or about December 30, 2020, subject to the satisfaction of customary closing conditions.

Kinnate Biopharma (NASDAQ: KNTE) 9.1% HIGHER; has seen coverage initiated by at least 4 Wall Street firms today. All firms - Goldman Sachs, Piper Sandler, Wedbush, and SVB Leerink - are bullish on KNTE as they rated the stock with a Buy or equivalent rating.

IMV Inc. (Nasdaq: IMV) 8.9% HIGHER; reported an update on the development of its vaccine candidate, DPX-COVID-19, for the prevention of COVID-19 infection caused by the novel coronavirus SARS-CoV-2.

Lemonade (NYSE: LMND) 5% LOWER; falls ahead of a lock-up expiration. About 44 million shares will be eligible to be sold on Tuesday.

AstraZeneca (NYSE: AZN) 4.1% HIGHER; A report in the Financial Times noted that authorities in the United Kingdom are set to approve the use of AstraZeneca’s (NYSE: AZN) Covid-19 vaccine as early as tomorrow.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

Goldman Sachs, S1, Pre-Open Losers, Pre-Open Winners, Pre Market Movers